Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Invested Capital (2017 - 2025)

Serina Therapeutics' Invested Capital history spans 9 years, with the latest figure at $4.6 million for Q3 2025.

  • For Q3 2025, Invested Capital rose 133.62% year-over-year to $4.6 million; the TTM value through Sep 2025 reached $4.6 million, up 133.62%, while the annual FY2024 figure was $509000.0, 101.58% up from the prior year.
  • Invested Capital for Q3 2025 was $4.6 million at Serina Therapeutics, up from $1.6 million in the prior quarter.
  • Across five years, Invested Capital topped out at $4.6 million in Q3 2025 and bottomed at -$32.3 million in Q4 2023.
  • The 5-year median for Invested Capital is -$6.3 million (2022), against an average of -$11.3 million.
  • The largest annual shift saw Invested Capital tumbled 1472.76% in 2021 before it surged 133.62% in 2025.
  • A 5-year view of Invested Capital shows it stood at -$11.8 million in 2021, then tumbled by 155.25% to -$30.1 million in 2022, then dropped by 7.05% to -$32.3 million in 2023, then surged by 101.58% to $509000.0 in 2024, then skyrocketed by 813.16% to $4.6 million in 2025.
  • Per Business Quant, the three most recent readings for SER's Invested Capital are $4.6 million (Q3 2025), $1.6 million (Q2 2025), and $1.6 million (Q1 2025).